12 13 In the UK, surveys have found variation in willingness to have a vaccine between ethnic groups. Surveys in 2021 report that between 50% and 60% of all respondents worldwide would be willing to receive a covid-19 vaccine, with wide variations across countries.
In this practice pointer we offer on overview of vaccine hesitancy and some approaches that clinicians and policymakers can adopt at the individual and community levels to help people make informed decisions about covid-19 vaccination. 2 3 4 A major threat to the impact of vaccination in preventing disease and death from covid-19 is low uptake of vaccines.
Vaccines for covid-19 are also safe, with extremely low risks of severe adverse events. 1 Vaccination is highly effective at reducing severe illness and death from covid-19. Rollout of covid-19 vaccination is well underway, with more than 700 million doses given worldwide as of April 2021. No single intervention is likely to be able to address vaccine hesitancyĬonsider barriers to uptake of vaccination at a population level and in groups who have lower rates of vaccine uptakeĭevelop local approaches by engaging members of the community and co-producing communications and materials that meet population needs Lack of confidence in vaccines for covid-19 poses direct and indirect threats to health, and could derail efforts to end the current pandemicĬoncerns about unknown future effects, side effects, and a lack of trust are common reasons given by people who say they are unlikely to have a covid-19 vaccine
0 kommentar(er)
